Company Antibiotice S.A.

ATB

ROATBIACNOR9

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Bucharest S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
1.935 ^RON	+1.31%		+6.03%	+38.71%

2023	Antibiotice S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Antibiotice S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Antibiotice SA is a Romania-based company primarily active in the pharmaceutical industry. The Company manufactures drugs in five pharmaceutical forms: powder for injectable solutions and suspensions, capsules, tablets, suppositories and preparations. The Company's products are designed to treat a range of diseases, including infectious, dermatology, cardiovascular, digestive and musculoskeletal system related. The Company operates eight certified production lines. Its portfolio includes products for human and veterinary use, pharmaceutical ingredients and biological fertilizers. Additionally, the Company is engaged in the research and development activities.

Number of employees: 1,350

RON in Million	2021	Weight	2022	Weight	Delta
Pharmaceutical Products 100.0 %	366	100.0 %	483	100.0 %	+31.80%

RON in Million	2021	Weight	2022	Weight	Delta
Romania 100.0 %	366	100.0 %	483	100.0 %	+31.80%

Managers	Title	Age	Since
Ioan Nani CEO	Chief Executive Officer	64	86-12-31
Paula-Luminita Coman DFI	Director of Finance/CFO	56	90-12-31
Cornelia Moraru CTO	Chief Tech/Sci/R&D Officer	58	03-01-04
Cerasela-Simona Moraru IRC	Investor Relations Contact	-	-
Mihaela Murariu HRO	Human Resources Officer	46	22-09-06
Liviu Vatavu LAW	General Counsel	51	19-01-08
Ovidiu Bataga SAM	Sales & Marketing	46	01-01-31
Vasile Chebac PRN	Corporate Officer/Principal	69	71-12-31

Members of the board	Title	Age	Since
Ioan Nani CEO	Chief Executive Officer	64	86-12-31
Ionel Damian BRD	Director/Board Member	52	21-04-20
Mihai Trifu BRD	Director/Board Member	41	21-08-25
Catalin-Codrut Popescu BRD	Director/Board Member	48	21-08-25
Lucian Timofticiuc CHM	Chairman	49	20-09-15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	671,338,040	117,937,079 ( 17.57 %)	0	17.57 %

Name	Equities	%	Valuation
Oltenia SIF SA (Investment Management) 10.06 %	67,549,475	10.06 %	25 M lei
Raiffeisen Asset Management SAI SA 0.5803 %	3,895,648	0.5803 %	1 M lei
Evergent Investments SA (Investment Management) 0.4913 %	3,298,291	0.4913 %	1 M lei
BT Asset Management SAI SA 0.3947 %	2,650,000	0.3947 %	996 215 lei
Erste Asset Management SAI SA 0.3430 %	2,302,390	0.3430 %	865 537 lei
Eurobank EFG Asset Management M.F.M.C. SA 0.3407 %	2,287,231	0.3407 %	859 839 lei
Generali Investments LLC 0.1856 %	1,245,864	0.1856 %	468 358 lei
Danske Bank A/S (Investment Management) 0.1523 %	1,022,722	0.1523 %	384 472 lei
St. Galler Kantonalbank AG (Private Banking) 0.1127 %	756,490	0.1127 %	284 387 lei
Karoll Capital Management Plc 0.1106 %	742,195	0.1106 %	279 013 lei

Antibiotice SA

Str. Valea Lupului, Nr. 1

707410, Iasi

+40 23 220 9000

http://www.antibiotice.ro

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ANTIBIOTICE S.A.	+38.71%	275M
ELI LILLY AND COMPANY	+24.60%	672B
NOVO NORDISK A/S	+24.08%	550B
JOHNSON & JOHNSON	-5.63%	351B
MERCK & CO., INC.	+15.37%	317B
ABBVIE INC.	+7.38%	292B
ASTRAZENECA PLC	+3.26%	211B
NOVARTIS AG	+0.78%	203B
PFIZER, INC.	-9.69%	144B
AMGEN INC.	-6.63%	141B

Other Pharmaceuticals